Key Highlights

  • T1 Energy Penny Stock closed at $3.73 on Thursday, down 3.37%, on below-average volume.
  • Investors are weighing a recent $50 million convertible note raise to fund Phase 1 of its Austin, Texas solar plant.
  • A brokerage expects a new U.S. solar rule could ease module pricing pressure from excess inventory.
  • Debt-to-equity sits near 283%, and negative margins and free Cash Flow keep dilution risk in focus.

Penny Stock Slips as Financing Worries Outweigh Policy Hopes

T1 Energy (NYSE:TE), a penny stock from the Austin, Texas solar manufacturer formerly known as FREYR Battery, closed Thursday at $3.73, down 3.37%. Industrials were soft and Treasury yields sat near multi-decade highs, with the 10-year around 5.3%, a pressure point for capital-intensive, leveraged solar names.

No company-specific announcement is behind the decline, and the broader sector fund edged higher after hours.

A New Solar Rule Could Ease Pricing Pressure

Investors are weighing optimism around a new U.S. solar rule that a brokerage expects could ease module pricing pressure from excess inventory. T1 runs its G1 Dallas plant in Wilmer, Texas, which has 5 gigawatts of annual module capacity, and is building cell Manufacturing capacity to support domestic content requirements. It became a leading U.S. solar manufacturer after buying solar Assets in December 2024.

A Strained Balance Sheet Keeps Dilution Risk in View

A recent $50 million convertible note raise will fund Phase 1 of the cell plant, but fundamentals remain strained. Margins are negative, free cash flow is negative, and debt-to-equity is near 283% with heavy long-term debt, so how the company funds growth and whether it dilutes holders remain central questions.

Cell Plant Funding and Module Pricing Will Decide the Next Move

The stock is caught between a possible policy tailwind and a balance sheet that leaves little room for setbacks. A small decline on below-average Volume suggests investors are waiting for evidence rather than reacting to a new development.

Markers to watch are details of the new rule and its effect on module prices, progress on the cell facility, any further financing or conversion of the notes, and third-quarter results. The shares trade within a 52-week range of $2.29 to $12.49.